Table 3: Serotype and macrolide resistance distribution.

 

cMLS(B) Phenotype

iMLS(B) phenotype

M phenotype

Prevalence

Serotype I

1 (50%)

1(50%)

0%

2 (5.1%)

Serotype II

4 (80%)

1 (20%)

0%

5 (12.8%)

Serotype III

9 (69.2%)

3 (23.1%)

1 (7.7%)

13 (33.3%)

Other serotypes

17 (89.5%)

0%

2 (10.5%)

19 (48.7%)

Total

31(79.4%)

5 (12.8%)

3 (7.7%)

39 (100%)